{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT02352077",
      "OrgStudyIdInfo": {
        "OrgStudyId": "CAS-XDA-SCI/IGDB"
      },
      "Organization": {
        "OrgFullName": "Chinese Academy of Sciences",
        "OrgClass": "OTHER_GOV"
      },
      "BriefTitle": "NeuroRegen Scaffold™ With Stem Cells for Chronic Spinal Cord Injury Repair",
      "OfficialTitle": "Safety and Efficacy of NeuroRegen Scaffold™ With Bone Marrow Mononuclear Cells or Mesenchymal Stem Cells for Chronic Spinal Cord Injury Repair"
    },
    "StatusModule": {
      "StatusVerifiedDate": "October 2016",
      "OverallStatus": "Unknown status",
      "LastKnownStatus": "Enrolling by invitation",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "January 2015"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "December 2021",
        "PrimaryCompletionDateType": "Anticipated"
      },
      "CompletionDateStruct": {
        "CompletionDate": "December 2021",
        "CompletionDateType": "Anticipated"
      },
      "StudyFirstSubmitDate": "January 20, 2015",
      "StudyFirstSubmitQCDate": "January 30, 2015",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "February 2, 2015",
        "StudyFirstPostDateType": "Estimate"
      },
      "LastUpdateSubmitDate": "December 21, 2020",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "December 23, 2020",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Principal Investigator",
        "ResponsiblePartyInvestigatorFullName": "Jianwu Dai",
        "ResponsiblePartyInvestigatorTitle": "Principal Investigator of Regenerative Medicine Laboratory, Institute of Genetics and Developmental Biology, CAS",
        "ResponsiblePartyInvestigatorAffiliation": "Chinese Academy of Sciences"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Chinese Academy of Sciences",
        "LeadSponsorClass": "OTHER_GOV"
      },
      "CollaboratorList": {
        "Collaborator": [
          {
            "CollaboratorName": "Affiliated Hospital of Logistics University of CAPF",
            "CollaboratorClass": "OTHER"
          },
          {
            "CollaboratorName": "The First Affiliated Hospital of Soochow University",
            "CollaboratorClass": "OTHER"
          },
          {
            "CollaboratorName": "First Hospitals affiliated to the China PLA General Hospital",
            "CollaboratorClass": "OTHER_GOV"
          }
        ]
      }
    },
    "OversightModule": {
      "OversightHasDMC": "No"
    },
    "DescriptionModule": {
      "BriefSummary": "The purpose of this study is to assess the safety and efficacy of NeuroRegen scaffold with bone marrow mononuclear cells (BMMCs) or mesenchymal stem cells (MSCs) in patients with chronic spinal cord injury."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Spinal Cord Injury"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 1"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "N/A",
        "DesignInterventionModel": "Single Group Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "None (Open Label)"
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "30",
        "EnrollmentType": "Actual"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "NeuroRegen Scaffold with BMMCs or MSCs transplantation",
            "ArmGroupType": "Experimental",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: NeuroRegen scaffold with BMMCs or MSCs transplantation"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Biological",
            "InterventionName": "NeuroRegen scaffold with BMMCs or MSCs transplantation",
            "InterventionDescription": "Patients with chronic SCI (ASIA grade A) will receive NeuroRegen Scaffold with bone marrow mononuclear cells (BMMCs) or mesenchymal stem cells (MSCs) transplantation after localized scars cleared and after surgery patients will undergo a comprehensive rehabilitation, psychological and nutritional measures.",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "NeuroRegen Scaffold with BMMCs or MSCs transplantation"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Safety Evaluation Number of patients with adverse events",
            "PrimaryOutcomeDescription": "Number of patients with adverse events is as a measure of safety and tolerability after collagen scaffold with MSCs transplantation.",
            "PrimaryOutcomeTimeFrame": "6 months"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Improvements in Neurophysiological Measures omatosensory Evoked Potentials (SSEP) and Motor Evoked Potentials (MEP) monitoring will be assessed",
            "SecondaryOutcomeDescription": "Somatosensory Evoked Potentials (SSEP) and Motor Evoked Potentials (MEP) monitoring will be assessed before and after transplantation.",
            "SecondaryOutcomeTimeFrame": "12 months"
          },
          {
            "SecondaryOutcomeMeasure": "Improvements in ASIA Impairment Scale",
            "SecondaryOutcomeDescription": "American Spinal Injury Assessment Scale of A, B, C, D or E will be assessed before and after transplantation.",
            "SecondaryOutcomeTimeFrame": "12 months"
          },
          {
            "SecondaryOutcomeMeasure": "Improvements in Independence Measures and Quality of Life",
            "SecondaryOutcomeDescription": "Functional Independence Measure (FIM) and the Quality of Life Questionnaire (EQ 5D) will be assessed before and after transplantation.",
            "SecondaryOutcomeTimeFrame": "12 months"
          },
          {
            "SecondaryOutcomeMeasure": "Improvements in Pain assessed based on Visual analog scale (VAS)",
            "SecondaryOutcomeDescription": "Pain intensity will be assessed based on Visual analog scale (VAS) before and after transplantation.",
            "SecondaryOutcomeTimeFrame": "12 months"
          },
          {
            "SecondaryOutcomeMeasure": "Improvements in Urinary and Bowel Function assessed based on bladder pressure monitory before and after transplantation",
            "SecondaryOutcomeDescription": "The ability to feel and control urination and bowel will be assessed based on bladder pressure monitory before and after transplantation.",
            "SecondaryOutcomeTimeFrame": "12 months"
          },
          {
            "SecondaryOutcomeMeasure": "Changes at the Transplantation Site in Spinal Cord by Magnetic Resonance Imaging (MRI)",
            "SecondaryOutcomeDescription": "The MRI at the transplantation site will be assessed before and after transplantation.",
            "SecondaryOutcomeTimeFrame": "12 months"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nMale or female, 18-65 years old.\nCompletely spinal cord injury at the cervical and thoracic level (C5-T12).\nClassification ASIA A with no significant further improvement.\nPatients signed informed consent.\nAbility and willingness to regular visit to hospital and follow up during the protocol Procedures.\n\nExclusion Criteria:\n\nA current diagnosis of any primary diseases affecting limb functions (e.g., trauma, infection, tumors, congenital malformations, peripheral muscular dystrophy, Huntington's disease, Parkinson's disease).\nSerious complications (e.g., hydronephrosis due to renal insufficiency, severe bedsores (Ⅲ° above), lower extremity venous thrombosis, severe myositis ossificans).\nHistory of life threatening allergic or immune-mediated reaction.\nClinically significant abnormalities in routine laboratory examinations (hematology, electrolytes, biochemistry, liver and kidney function tests, urinanalysis).\nHistory of mental illness or suicide risk, with a history of epilepsy or other central nervous system disorders.\nSevere arrhythmias (e.g., ventricular tachycardia, frequent superventricular tachycardia, atrial fibrillation, and atrial flutter) or cardiac degree II or above conduction abnormalities displayed via 12-lead ECG.\nLactating and pregnant woman.\nAlcohol drug abuse /dependence.\nParticipated in any other clinical trials within 3 months before the enrollment.\nA drug or treatment known to cause effect on the central nervous system during the past four weeks.\nA drug or treatment known to cause major organ system toxicity during the past four weeks.\nPoor compliance, difficult to complete the study.\nAny other conditions that might increase the risk of subjects or interfere with the clinical trial.",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "18 Years",
      "MaximumAge": "65 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Jianwu Dai, Ph.D",
            "OverallOfficialAffiliation": "Chinese Academy of Sciences",
            "OverallOfficialRole": "Principal Investigator"
          },
          {
            "OverallOfficialName": "Sai Zhang, M.D",
            "OverallOfficialAffiliation": "Affiliated Hospital of Logistics Universtiy of CAPF",
            "OverallOfficialRole": "Study Chair"
          },
          {
            "OverallOfficialName": "Huilin Yang, Ph.D",
            "OverallOfficialAffiliation": "The First Affiliated Hospital of Soochow University",
            "OverallOfficialRole": "Study Chair"
          },
          {
            "OverallOfficialName": "Shuxun Hou",
            "OverallOfficialAffiliation": "First Hospitals affiliated to the China PLA General Hospital",
            "OverallOfficialRole": "Study Chair"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "First Hospitals affiliated to the China PLA General Hospital",
            "LocationCity": "Beijing",
            "LocationZip": "100037",
            "LocationCountry": "China"
          },
          {
            "LocationFacility": "The First Affiliated Hospital of Soochow University",
            "LocationCity": "Suzhou",
            "LocationZip": "215006",
            "LocationCountry": "China"
          },
          {
            "LocationFacility": "Affiliated Hospital of Logistics Universtiy of CAPF",
            "LocationCity": "Tianjin",
            "LocationZip": "300162",
            "LocationCountry": "China"
          }
        ]
      }
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000013119",
            "ConditionMeshTerm": "Spinal Cord Injuries"
          },
          {
            "ConditionMeshId": "D000014947",
            "ConditionMeshTerm": "Wounds and Injuries"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000013118",
            "ConditionAncestorTerm": "Spinal Cord Diseases"
          },
          {
            "ConditionAncestorId": "D000002493",
            "ConditionAncestorTerm": "Central Nervous System Diseases"
          },
          {
            "ConditionAncestorId": "D000009422",
            "ConditionAncestorTerm": "Nervous System Diseases"
          },
          {
            "ConditionAncestorId": "D000020196",
            "ConditionAncestorTerm": "Trauma, Nervous System"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M15068",
            "ConditionBrowseLeafName": "Spinal Cord Injuries",
            "ConditionBrowseLeafAsFound": "Spinal Cord Injury",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M16837",
            "ConditionBrowseLeafName": "Wounds and Injuries",
            "ConditionBrowseLeafAsFound": "Injury",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M15067",
            "ConditionBrowseLeafName": "Spinal Cord Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M4894",
            "ConditionBrowseLeafName": "Central Nervous System Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M21176",
            "ConditionBrowseLeafName": "Trauma, Nervous System",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC10",
            "ConditionBrowseBranchName": "Nervous System Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC26",
            "ConditionBrowseBranchName": "Wounds and Injuries"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          }
        ]
      }
    }
  }
}